UNIGE document Scientific Article
previous document  unige:131896  next document
add to browser collection
Title

Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy

Authors show hidden authors show all authors [1 - 9]
Published in Pediatric Transplantation. 2020, vol. 24, no. 1, p. e13611
Abstract Despite growing interest about the impact of donor-specific HLA antibodies (DSA) in LT limited data are available for pediatric recipients. Our aim was to perform a retrospective single-center chart review of children (0-16 years) having undergone LT between January 1, 2005 and December 31, 2017, to characterize DSA, to identify factors associated with the development of de novo DSA, and to analyze potential associations with the diagnosis of TCMR. Information on patient- and donor-characteristics and LB reports were analyzed retrospectively. Serum obtained before LT and at LB was analyzed for presence of recipient HLA antibody using Luminex® technology. MFI > 1000 was considered positive. In 63 pediatric LT recipients with a median follow-up of 72 months, the overall prevalence of de novo DSA was 60.3%. Most were directed against class II antigens (33/38, 86.8%). Preformed DSA were present in 30% of patients. Twenty-eight (28/63) patients (44.4%) presented at least one episode of TCMR, mostly (12/28, 43%) moderate (Banff 6-7). De novo DSA were significantly more frequent in patients with TCMR than in patients without (75% vs 48.6%, P = .03), and patients with preformed and de novo DSA had a significantly higher rate of TCMR than patients without any DSA (66.7% vs 20%, P = .02). Neither preformed DSA nor de novo DSA were associated with frequency or severity of TCMR. Recipients with lower weight at LT developed de novo DSA more frequently (P = .04). De novo DSA were highly prevalent in pediatric LT recipients. Although associated with the development of TCMR, they did not appear to impact the frequency or severity of TCMR or graft survival. Instead, de novo DSA may suggest a state of insufficient IS.
Keywords Banff criteriaT-cellDonor-specific antibodyGraft survivalMean fluorescence intensityMediated rejection
Identifiers
PMID: 31682057
Full text
Article (Published version) (455 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Métastases du foie (657)
Recherche clinique en chirurgie pédiatrique (886)
Citation
(ISO format)
SCHLUCKEBIER, Dominique et al. Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy. In: Pediatric Transplantation, 2020, vol. 24, n° 1, p. e13611. doi: 10.1111/petr.13611 https://archive-ouverte.unige.ch/unige:131896

145 hits

2 downloads

Update

Deposited on : 2020-03-09

Export document
Format :
Citation style :